质子道化允许在癌细胞中进行质子合电子转移过程
Tong Zhang1, Arindam Ghosh2,3, Lisa Behringer-Pließ3
1Department of Chemistry, University of Antwerp, Antwerp 2020, Belgium.
JACS Au
|December 30, 2024
概括
这项研究引入了一种新的质子合电子转移 (PCET) 方法来激活C-H键,通过向线粒体电子运输链 (ETC) 在癌细胞中提供光动力疗法 (PDT) 的新方法. PCET策略有效诱导氧化应激,并破坏癌细胞中的线粒体功能.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 摄影化学的使用.
背景情况:
- 质子合电子转移 (PCET) 对于生物系统中激活C-H键至关重要.
- 在缺氧下,癌细胞依赖于线粒体电子运输链 (ETC) 作为关键的氧化还原调节器.
- 光动力疗法 (PDT) 是一种癌症治疗方式,利用光产生反应性氧物种 (ROS).
研究的目的:
- 通过调节质子道化,在癌细胞中开发一种简单的PCET过程.
- 设计一种替代的PDT,可以在缺氧癌细胞中耗尽线粒体ETC.
- 研究PCET对线粒体内膜潜能 (MMP) 和形态学的影响.
主要方法:
- 使用光终身成像显微镜 (FLIM) 来监测MMP变化.
- 照射癌细胞30分钟,观察PCET诱导的影响.
- 使用光发光实验和密度函数理论 (DFT) 计算来理解质子道.
主要成果:
- 观察到平均光寿命的变化和辐射后信号的显著下降,表明氧化应激.
- 证明了PCET诱导的线粒体形态的重组,从管状结构变成类似囊泡的结构.
- 证实PCET促进ROS诱导的氧化应激,导致线粒体功能障碍.
结论:
- 开发的PCET策略为癌症治疗中的光动力学疗法提供了一个有希望的替代方案.
- 在PCET中调节质子道化可以有效地准和破坏癌细胞中的线粒体功能.
- 这项研究提供了关于质子道在PCET中的作用及其在癌症治疗中的应用的见解.
相关概念视频
Electron Transport Chain: Complex I and II
9.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.5K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
ATP Driven Pumps I: An Overview
7.7K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
7.7K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Positron Emission Tomography
3.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
3.9K
The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K


